Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Alnylam Pharmaceuticals I...

    NASDAQ: ALNY · Real-Time Price · USD
    267.49
    16.34 (6.51%)
    At close: May 12, 2025, 1:47 PM

    Alnylam Pharmaceuticals Revenue

    Alnylam Pharmaceuticals reported an annual revenue of $2.25B, reflecting a 22.97% growth. For the quarter ending March 31, 2025, Alnylam Pharmaceuticals generated $594.19M in revenue.
    Revenue (ttm)
    $2.25B
    Revenue Growth
    22.97%
    Price / Sales Ratio
    13.36
    Revenue / Employee
    $1.01M
    Employees
    2,230
    Market Cap
    34.88B

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist